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Abstract
OBJECTIVE—To assess national trends in ectopic pregnancy incidence among assisted 
reproductive technology users and identify risk factors associated with ectopic pregnancy.
METHODS—We identified 553,577 pregnancies reported to the National ART Surveillance 
System between 2001 and 2011. Of those, 9,480 were ectopic, of which 485 were heterotopic. As 
a result of small numbers, ectopic and heterotopic pregnancies were combined for analysis. We 
assessed temporal trends in annual ectopic pregnancy rates using Poisson regression. We used log-
binomial regression models with generalized estimating equations for correlated outcomes within 
clinics to calculate unadjusted and adjusted risk ratios for the association between ectopic 
pregnancy and selected patient characteristics and treatment factors.
RESULTS—The rate of ectopic pregnancy declined from 2.0% (n5735, 95% confidence interval 
[CI] 1.9–2.2) in 2001 to 1.6% (n=968, 95% CI 1.5–1.7) in 2011 (P for trend ,.001). The ectopic 
pregnancy rate ranged from 2.0% (n=7,469, 95% CI 1.9–2.0) for fresh, nondonor cycles to 1.0% 
(n=641, 95% CI 0.9–1.1) for fresh, donor cycles. Among fresh, nondonor cycles, the rate of 
ectopic pregnancy was 1.6% (95% CI 1.4–1.7) when one embryo was transferred compared with 
1.7% (95% CI 1.7–1.8), 2.2% (95% CI 2.1–2.3), and 2.5% (95% CI 2.4–2.6) when two, three, or 
four or more embryos were transferred, respectively (adjusted risk ratios 1.11, 95% CI 0.94–0.30; 
1.33, 95% CI 1.12–1.56; and 1.49, 95% CI 1.25–1.78).
CONCLUSION—Ectopic pregnancy incidence after assisted reproductive technology has 
decreased over time, but factors such as multiple embryo transfer increase the risk of ectopic 
pregnancy.
Ectopic pregnancy is a leading cause of maternal morbidity and mortality with a pregnancy-
related mortality of 31.9 deaths per 100,000 pregnancies.1 The use of assisted reproductive 
technology (ART) has traditionally been thought to increase the risk of ectopic pregnancy 
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compared with the general population,2–4 but reported rates among the ART population vary 
from 0.8% to 8.6%.4–16 In studies conducted in either individual U.S. clinics or in other 
countries, several factors were associated with increased risk of ectopic pregnancy after 
ART and include tubal factor infertility, use of assisted hatching, and intracytoplasmic 
sperm injection, fresh compared with frozen embryo transfers, day of embryo transfer, and 
the hormonal milieu specific to ovarian stimulation.4–7,9–13,15–18 Interpretation and 
generalizability of such results is difficult because ART practices vary between clinics and 
across different countries.
The field of ART is rapidly changing, and there have been no published reports on the trends 
and correlates of ectopic pregnancy over the past decade. Thus, the objectives of this study 
were to use data from the National ART Surveillance System to assess changes in the 
incidence of ectopic pregnancy between 2001 and 2011 and to identify risk factors for 
ectopic pregnancy among women undergoing ART.
MATERIALS AND METHODS
We used data from the Centers for Disease Control and Prevention's National ART 
Surveillance System. All U.S. fertility clinics performing ART are required to report annual 
data on all ART procedures to the Centers for Disease Control and Prevention. Data 
collected include patient demographic characteristics, medical and obstetric history, 
infertility diagnosis, and resultant pregnancies and births, if any. The Centers for Disease 
Control and Prevention estimates that National ART Surveillance System captures 
information on more than 95% of all ART procedures performed in the United States.19
This study included transcervical embryo transfer procedures performed from January 1, 
2001, to December 31, 2011, that resulted in a clinical intrauterine pregnancy, an ectopic 
pregnancy, or a hetero-topic pregnancy. A clinical intrauterine pregnancy was reported when 
ultrasonography confirmed the presence of a gestational sac within the uterus. If there was 
missing ultrasound data, a clinical intrauterine pregnancy was confirmed by a documented 
birth, spontaneous abortion, or induced abortion. An ectopic pregnancy was reported when a 
gestational sac was confirmed to be outside the uterus by ultrasonography or by high serial 
serum β-human chorionic gonadotropin values in the absence of an intrauterine pregnancy 
on ultrasonography. A heterotopic pregnancy was reported when a clinical intrauterine 
pregnancy was confirmed in combination with an ectopic pregnancy. For this study, an 
ectopic pregnancy was defined as a clinical ectopic pregnancy or a clinical heterotopic 
pregnancy.
Rates of ectopic pregnancy were calculated by dividing the total number of ectopic and 
heterotopic pregnancies by the sum of intrauterine, ectopic, and heterotopic pregnancies and 
were reported as percentages. We evaluated the trend in ectopic pregnancy incidence during 
the study period by calculating the ectopic pregnancy rate by year. Statistically significant 
trends in ectopic pregnancy rate were determined using Poisson regression.
Ectopic pregnancy rates were classified on the basis of type of in vitro fertilization-embryo 
transfer (IVF-ET) procedure as either fresh or frozen cycles and by oocyte donor status. A 
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fresh cycle was reported when the oocytes were retrieved and the resultant embryos 
transferred during the current IVF-ET cycle. A frozen–thawed cycle was reported when 
cryopreserved embryos resulting from a previous cycle were thawed and transferred during 
the current IVF-ET cycle. Nondonor cycles were reported when oocytes were retrieved from 
the patient; donor cycles were reported when oocytes or embryos were obtained from a 
donor, but the embryos were transferred to the patient. Stratification by these two categories 
resulted in four types of IVF-ET cycles: 1) fresh, nondonor; 2) fresh, donor; 3) frozen–
thawed, nondonor; and 4) frozen–thawed, donor. Risk ratios were calculated to determine 
the relative risk of ectopic pregnancy for these four types of IVF-ET cycles using fresh, 
nondonor cycles as the referent.
All further analyses were restricted to fresh, nondonor cycles, the most common type of 
IVF-ET performed, accounting for 68% of all cycles. Risk factors evaluated were patient 
age, race or ethnicity, number of prior ART cycles, number of prior spontaneous abortions, 
number of prior live births, infertility diagnosis (male factor, tubal factor, endometriosis, 
uterine factor, ovulatory disorder, and diminished ovarian reserve), year of ART procedure, 
use of assisted hatching, use of intracytoplasmic sperm injection, day of embryo transfer 
(day 3 or day 5, typically corresponding to cleavage or blastocyst stage embryos, 
respectively, or other), number of embryos transferred, number of supernumerary embryos 
cryopreserved, ovarian hyperstimulation syndrome, and follicle-stimulating hormone (FSH) 
dosage. Infertility diagnoses were not mutually exclusive. The National ART Surveillance 
System does not include information on previous ectopic pregnancy. The amount of missing 
data was less than 0.5% for all variables except for FSH dosage (2.6%) and race or ethnicity 
(41.2%). As a result of the large proportion of missing data for race and ethnicity, this 
information should be interpreted with caution because it may be prone to bias.20 To assess 
whether clinic volume affected ectopic pregnancy rates, we compared rates of ectopic 
pregnancy according to quartiles of clinic volume based on the total number of cycles in 
each clinic during the most recent study year, 2011. We found no evidence of differences in 
rates of ectopic pregnancy by clinic volume (range 1.5–1.7%, X2 P=.24) and therefore did 
not include this information.
We compared the distribution of these risk factors between ectopic pregnancies and 
intrauterine pregnancies using the X2 test at a significance level of P<.05. We used log-
binomial regression models with generalized estimating equations for correlated outcomes 
within clinics to calculate unadjusted and adjusted risk ratios (RRs) and 95% confidence 
intervals (CIs) for the association between ectopic pregnancy and selected risk factors. The 
final adjusted model included the variables listed except for race or ethnicity and FSH 
dosage. Race or ethnicity was excluded from the model because of the large amount of 
missing data. Follicle-stimulating hormone dosage was excluded because FSH was not used 
for stimulation in all cycles. Data were analyzed using SAS 9.3. This research was approved 
by the institutional review board at the Centers for Disease Control and Prevention.
RESULTS
A total of 553,577 clinical intrauterine, ectopic, and heterotopic pregnancies were included 
in our study; of those, 9,480 (1.7%) were ectopic, including 485 (0.09%) that were 
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heterotopic. Heterotopic pregnancy rates were 0.10% for fresh, nondonor cycles and 0.06% 
for all other cycle types. Heterotopic pregnancies were not further characterized as a result 
of small cell sizes and data suppression requirements. All further analyses included 
heterotopic pregnancies as ectopic pregnancies. For all transfer types combined, the ectopic 
pregnancy rate among women undergoing ART procedures declined from 2.0% (n5735, 
95% CI 1.9–2.2) in 2001 to 1.6% (n=968, 95% CI 1.5–1.7) in 2011; decreases were noted 
for both frozen–thawed embryo transfer cycles and for fresh embryo transfer cycles (Fig. 1). 
P values for trend of ectopic pregnancy rate over time were 0.24 and 0.77 for cleavage-stage 
and blastocyst-stage embryo transfers, respectively, by Poisson regression (see the 
Appendix, available online at http://links.lww.com/AOG/A580). The ectopic pregnancy rate 
varied significantly by type of ART procedure performed (Table 1). Fresh, nondonor cycles 
had the highest ectopic pregnancy rate (2.0%, 95% CI 1.9–2.0), and fresh, donor cycles had 
the lowest ectopic pregnancy rate (1.0%, 95% CI 0.9–1.1).
Among fresh, nondonor cycles, the proportions of various patient characteristics and ART 
treatment factors differed between ectopic pregnancies and intrauterine pregnancies (Table 
2). Compared with intrauterine pregnancies, ectopic pregnancies were more common among 
women aged 35 years or older and among Asian and non-Hispanic black women. Women 
with ectopic pregnancies had a higher frequency of having had at least one prior ART cycle 
and a lower frequency of having had a prior birth compared with women with intrauterine 
pregnancies. Compared with intrauterine pregnancies, ectopic pregnancies were more 
common with tubal factor infertility, endometriosis, uterine factor infertility, and diminished 
ovarian reserve and less common with male factor infertility and ovulatory disorders. 
Assisted hatching was used more frequently and intracytoplasmic sperm injection was used 
less frequently among ectopic pregnancies than among intrauterine pregnancies. Ectopic 
pregnancies were more likely when three or more embryos were transferred per cycle and 
less likely when extra embryos were cryo-preserved. When FSH was used as the ovarian 
stimulation method, higher FSH doses were observed among ectopic pregnancies compared 
with intrauterine pregnancies, especially when FSH dosage was higher than 3,500 
international units (38.5% compared with 30.1%, respectively; Table 2).
In the adjusted analysis, being aged 30–43 years was associated with an increased risk for 
ectopic pregnancy compared with being younger than 30 years; although the highest rate 
was seen among the 41- to 43-year-olds (2.4%), the risk ratio was not significantly different 
from the risk ratios for women aged 30–34, 35–37, 38–40, and 44 years and older (Table 3). 
Having had more than one prior ART cycle was also associated with an increased risk for 
ectopic pregnancy (adjusted risk ratios 1.21, 95% CI 1.11–1.31). Of all infertility diagnoses, 
tubal factor infertility was the only one significantly associated with increased risk for 
ectopic pregnancy (adjusted RR 1.25, 95% CI 1.16–1.35). The rate of ectopic pregnancy 
also increased with increasing number of embryos transferred per cycle; the rate of ectopic 
pregnancy was 1.6% (95% CI 1.4–1.7) when one embryo was transferred compared with 
1.7% (95% CI 1.7–1.8), 2.2% (95% CI 2.1–2.3), and 2.5% (95% CI 2.4–2.6) when two, 
three, or four or more embryos were transferred, respectively. The highest risk occurred 
when four or more embryos were transferred compared with only one embryo transferred 
(adjusted RR 1.49, 95% CI 1.25–1.78) and the risk ratio was significantly different 
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compared with the risk ratios for cycles in which two or three embryos were transferred (P<.
001). Having had one (adjusted RR 0.71, 95% CI 0.66–0.77) or two or more (adjusted RR 
0.55, 95% CI 0.48–0.63) prior live births was negatively associated with ectopic pregnancy 
risk; the risk ratio for two or more prior births was statistically lower than having had one 
(P<.001). Finally, the risk of ectopic pregnancy was lower when male factor infertility was 
present compared with no male factor infertility (adjusted RR 0.85, 95% CI 0.79–0.92).
DISCUSSION
The overall national ectopic pregnancy rate in our study was 1.7%, a rate similar to the 
general population of 2%2 and consistent with other recent studies.21–23 We found that 
ectopic pregnancy incidence declined over the study period with the most pronounced 
decline seen with frozen embryo transfers. One explanation for this decline may be that rates 
of tubal factor infertility are also decreasing in women undergoing ART. Findings from a 
recent national study suggest that diagnosis of tubal factor infertility among ART cycles 
declined from 26.0 to 14.8% between 2000 and 2010.24 Multiple studies have demonstrated 
that women with tubal factor infertility have an increased risk of ectopic pregnancy after 
ART compared with those with other types of infertility diagnoses,4,6,9,12,15,16,21 and we 
found that tubal factor infertility significantly increased the risk of ectopic pregnancy by 
25%.
Declines in the transfer of three or more embryos during ART cycles may also contribute to 
decreasing rates of ectopic pregnancy.25 Similar to a previous report,21 we saw a dose–
response relationship between the risk of ectopic pregnancy and the number of embryos 
transferred during an ART cycle. Although earlier studies have not demonstrated this 
trend,4,10,12,15 more recent investigations are consistent with our findings,21,26 likely as a 
result of improvements in IVF techniques resulting in improved implantation potential, and 
increased odds of extrauterine implantation. Although the use of ultrasound guidance during 
embryo transfer procedures has increased since the late 1990s, a recent meta-analysis 
showed no improvement in ectopic pregnancy rates with its use.27
Fresh, nondonor cycles had the highest ectopic rate in our study, a finding that is consistent 
with previous studies.10,18,22,28 Elevated hormone levels seen with ovarian stimulation used 
in fresh cycles may alter the uterine environment during embryo transfer, causing increased 
uterine contractility, and result in retrograde movement of the embryo into the fallopian 
tube. Women undergoing donor cycles and frozen–thawed cycles are less likely to have had 
controlled ovarian hyperstimulation and therefore less likely to have elevated hormone 
levels. Indeed, we found lower ectopic pregnancy rates among these cycles. Although we 
found a lower incidence of ovarian hyperstimulation syndrome among ectopic pregnancies 
than among intrauterine pregnancies, the number of observations was small and included a 
heterogeneous group of women. Although we did not have information on estrogen levels 
during each ART cycle, higher estrogen levels have been reported among ectopic 
pregnancies compared with intrauterine pregnancies after ART and among frozen cycles in 
which women received hormone replacement.5,16
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In our study, older maternal age was associated with an increased risk of ectopic pregnancy 
in fresh, nondonor cycles. In the general population, older age is an unmodifiable risk factor 
for ectopic pregnancy with the highest incidence seen in the 35-year to 44-year age group. 
Explanations for this association include the accumulation of risk factors over time as a 
woman ages and changes in the anatomy and function of the fallopian tube that may 
predispose the embryo to extrauterine implantation.2
The primary strength of our study is that we used a large, population-based data set to 
analyze trends and risks for ectopic pregnancy in the ART population. It should be noted 
that, as a result of the large sample size of the National ART Surveillance System, even 
modest differences may be statistically significant although not clinically relevant. Our 
study is also subject to several limitations. First, the National ART Surveillance System does 
not collect information on patients’ history of prior ectopic pregnancy, a major risk factor 
for future ectopic pregnancy, and we could not link patients across the entire study period. In 
addition, the large amount of missing data on race and ethnicity prevented assessment of this 
variable. Next, data quality may have been heterogeneous during the study period because of 
improvements in the reporting system after 2004. Finally, our findings may not be 
generalizable to the general population of women because they may have different risk 
factors than women undergoing ART. Furthermore, pregnancies conceived using ART may 
be monitored more closely, which may result in more frequent identification of ectopic 
pregnancies than in spontaneously conceived pregnancies. It is also possible that some 
misclassification of ectopic pregnancies and miscarriages may have occurred.
Ectopic pregnancy can add to the emotional and financial burden of ART and further delay 
treatment success. Although characteristics such as maternal age and tubal factor infertility 
are unmodifiable risk factors for ectopic pregnancy, efforts to decrease the number of 
embryos transferred may further reduce ectopic pregnancy risk after ART.
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Incidence of ectopic pregnancy by year and fresh compared with frozen embryo transfers, 
United States, 2001–2011. P<.001 for trend for all transfer types by Poisson regression.
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Table 1
Incidence of Ectopic Pregnancy by Type of In Vitro Fertilization-Embryo Transfer Procedure in the United 
States, 2001-2011
IVF-ET Procedure Total No. of Pregnancies No. of Ectopic 
Pregnancies
Ectopic Pregnancy Rate 
(%)
RR 95% CI
All IVF-ET procedures 553,577 9,480 1.7 — —
Fresh, nondonor 379,023 7,469 2.0 Reference Reference
Fresh, donor 65,316 641 1.0 0.50 0.46–0.54
Frozen-thawed, nondonor 84,976 1,104 1.3 0.65 0.61–0.69
Frozen-thawed, donor 23,158 266 1.2 0.58 0.52–0.66
IVF-ET, in vitro fertilization-embryo transfer;RR, risk ratio;CI, confidence interval.
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Table 2
Characteristics of Ectopic Pregnancies Compared With Intrauterine Pregnancies by Patient and Assisted 
Reproductive Technology Treatment Factors for Fresh, Nondonor In Vitro Fertilization-Embryo Transfer 
Treatment Protocol, United States, 2001-2011
Characteristic Ectopic Pregnancy Intrauterine Pregnancy P (χ2)
Patient factors
    Age (y) <.001
        Younger than 30 938 (12.6) 58,143 (15.7)
        30-34 2,742 (36.7) 141,717 (38.1)
        35-37 1,817 (24.3) 86,713 (23.3)
        38-10 1,391 (18.6) 61,370 (16.5)
        41-13 543 (7.3) 21,929 (5.9)
        44 or older 38 (0.5) 1,682 (0.5)
    Race or ethnicity <.001
        White (non-Hispanic) 3,286 (44.0) 169,290 (45.6)
        Black (non-Hispanic) 313 (4.2) 11,988 (3.2)
        Asian 582 (7.8) 19,346 (5.2)
        Hispanic 356 (4.8) 17,301 (4.7)
        Missing or unknown 2,923 (39.1) 153,208 (41.2)
    Prior ART cycles <.001
        0 4,253 (57.0) 226,350 (60.9)
        1 1,447 (19.4) 68,721 (18.5)
        2 or more 1,765 (23.6) 76,351 (20.6)
    Prior spontaneous abortions
* .01
        0 5,176 (69.3) 262,042 (70.5)
        1 1,451 (19.4) 71,430 (19.2)
        2 or more 842 (11.3) 38,079 (10.3)
    Prior live births
        0 5,690 (76.4) 264,169 (71.3) <.001
        1 1,392 (18.7) 79,798 (21.5)
        2 or more 366 (4.9) 26,415 (7.1)
    Infertility diagnosis
        Male factor 2,646 (35.4) 146,582 (39.5) <.001
        No male factor 4,823 (64.6) 224,972 (60.6)
        Tubal factor
† 1,682 (22.5) 70,596 (19.0) <.001
        No tubal factor 5,787 (77.5) 300,958 (81.0)
        Endometriosis 1,094 (14.7) 49,992 (13.5) .003
        No endometriosis 6,375 (85.4) 321,562 (86.6)
        Uterine factor 373 (5.0) 16,676 (4.5) .037
        No uterine factor 7,096 (95.0) 354,878 (95.5)
        Ovulatory disorder
‡ 1,191 (16.0) 62,650 (16.9) .036
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Characteristic Ectopic Pregnancy Intrauterine Pregnancy P (χ2)
        No ovulatory disorder 6,278 (84.1) 308,904 (83.1)
        Diminished ovarian reserve 1,097 (14.7) 46,683 (12.6) <.001
        No diminished ovarian reserve 6,372 (85.3) 324,871 (87.4)
    Year of ART procedure .001
        2001-2003 1,862 (24.9) 86,580 (23.3)
        2004-2006 2,017 (27.0) 99,264 (26.7)
        2007-2009 2,128 (28.5) 112,338 (30.2)
        2010-2011 1,462 (19.6) 73,372 (19.8)
ART treatment factors
    Use of assisted hatching <.001
        No 4,374 (58.6) 230,295 (62.0)
        Yes 3,095 (41.4) 141,259 (38.0)
    Use of ICSI .004
        No 2,468 (33.1) 116,900 (31.5)
        Yes 4,993 (66.9) 254,324 (68.5)
    Day of embryo transfer <.001
        Cleavage stage 4,436 (59.4) 213,455 (57.5)
        Blastocyst stage 2,397 (32.1) 127,768 (34.4)
        Other 636 (8.5) 30,325 (8.2)
    No. of embryos transferred <.001
        1 410 (5.5) 25,343 (6.8)
        2 3,355 (44.9) 189,084 (50.9)
        3 2,261 (30.3) 101,167 (27.2)
        4 or more 1,443 (19.3) 55,958 (15.1)
    No. of supernumerary embryos cryopreserved <.001
        0 4,367 (58.7) 204,354 (55.2)
        1-2 1,088 (14.6) 56,460 (15.3)
        3-5 1,144 (15.4) 62,979 (17.0)
        6 or more 847 (11.4) 46,223 (12.5)
    Ovarian hyperstimulation syndrome .019
        Absent 7,383 (98.9) 366,052 (98.5)
        Present 86 (1.2) 5,501 (1.5)
    FSH dosage (international units)
§ <.001
        0-1,500 892 (12.3) 58,640 (16.2)
        1,501-2,000 769 (10.6) 49,139 (13.6)
        2,001-2,500 1,127 (15.5) 61,360 (16.9)
        2,501-3,000 1,037 (14.2) 53,138 (14.7)
        3,001-3,500 645 (8.9) 30,776 (8.5)
        3,501 or higher 2,795 (38.5) 109,090 (30.1)
ART, assisted reproductive technology;ICSI, intracytoplasmic sperm injection;FSH, follicle-stimulating hormone.
Data are n (%) unless otherwise specified.
*
Pregnancy loss at less than 20 weeks of gestation.
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†
Includes hydrosalpinx, tubal ligation (not reversed), and other tubal disease (not hydrosalpinx).
‡
Includes polycystic ovary syndrome.
§
A total of 2.6% of data was missing because FSH was not used in all cycles.
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Table 3
Risk of Ectopic Pregnancy by Patient and Assisted Reproductive Technology Treatment Factors for Fresh, 
Nondonor In Vitro Fertilization-Embryo Transfer, United States, 2001-2011





    Age (y)
        Younger than 30 1.6 Reference Reference
        30-34 1.9 1.20 (1.11-1.29) 1.21 (1.10-1.33)
        35-37 2.1 1.29 (1.19-1.40) 1.18 (1.06-1.31)
        38-10 2.2 1.40 (1.29-1.52) 1.19 (1.06-1.34)
        41-13 2.4 1.52 (1.36-1.70) 1.23 (1.04-1.45)
        44 or older 2.2 1.39 (1.02-1.91) 1.08 (0.68-1.70)
    Prior ART cycles
        0 1.8 Reference Reference
        1 2.1 1.12 (1.05-1.19) 1.05 (0.96-1.13)
        2 or more 2.3 1.23 (1.15-1.30) 1.21 (1.11-1.31)
    Prior spontaneous abortions
†
        0 1.9 Reference Reference
        1 2.0 1.03 (0.97-1.09) 0.97 (0.90-1.05)
        2 or more 2.2 1.12 (1.04-1.20) 1.09 (0.99-1.20)
    Prior live births
        0 2.1 Reference Reference
        1 1.7 0.77 (0.72-0.83) 0.71 (0.66-0.77)
        2 or more 1.4 0.63 (0.55-0.72) 0.55 (0.48-0.63)
    Infertility diagnosis
        Male factor 1.8 0.84 (0.80-0.89) 0.85 (0.79-0.92)
        No male factor 2.1 Reference Reference
        Tubal factor
‡ 2.3 1.23 (1.17-1.30) 1.25 (1.16-1.35)
        No tubal factor 1.9 Reference Reference
        Endometriosis 2.1 1.10 (1.03-1.17) 1.02 (0.94-1.11)
        No endometriosis 1.9 Reference Reference
        Uterine factor 2.2 1.12 (1.00-1.24) 1.04 (0.91-1.20)
        No uterine factor 2.0 Reference Reference
        Ovulatory disorder
§ 1.9 0.94 (0.88-1.00) 0.97 (0.89-1.06)
        No ovulatory disorder 2.0 Reference Reference
        Diminished ovarian reserve 2.3 1.19 (1.11-1.28) 1.08 (0.98-1.20)
        No diminished ovarian reserve 1.9 Reference Reference
    Year of ART procedure
        2001-2003 2.1 Reference Reference
        2004-2006 2.0 0.95 (0.87-1.03) 1.04 (0.95-1.14)
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Characteristic Ectopic Pregnancy Rate (%) Unadjusted RR (95% CI) Adjusted RR
*
 (95% CI)
        2007-2009 1.9 0.88 (0.81-0.96) 0.96 (0.87-1.05)
        2010-2011 2.0 0.93 (0.85-1.01) 1.04 (0.94-1.16)
ART treatment factors
    Use of assisted hatching
        No 1.9 Reference Reference
        Yes 2.1 1.15 (1.09-1.21) 1.01 (0.94-1.08)
    Use of ICSI
        No 2.1 Reference Reference
        Yes 1.9 0.93 (0.88-0.98) 1.01 (0.94-1.09)
    Day of embryo transfer
        Cleavage stage 2.0 Reference Reference
        Blastocyst stage 1.8 0.90 (0.86-0.96) 1.07 (0.98-1.16)
        Other 2.1 1.01 (0.92-1.11) 1.06 (0.95-1.18)
    No. of embryos transferred
        1 1.6 Reference Reference
        2 1.7 1.10 (0.98-1.22) 1.11 (0.94-1.30)
        3 2.2 1.37 (1.23-1.53) 1.33 (1.12-1.56)
        4 or more 2.5 1.58 (1.41-1.77) 1.49 (1.25-1.78)
    No. supernumerary embryos cryopreserved
        0 2.1 Reference Reference
        1-2 1.9 0.90 (0.84-0.96) 0.95 (0.87-1.05)
        3-5 1.8 0.85 (0.80-0.91) 0.96 (0.88-1.04)
        6 or more 1.8 0.86 (0.80-0.93) 0.99 (0.90-1.09)
    Ovarian hyperstimulation syndrome
        Absent 2.0 Reference Reference
        Present 1.5 0.78 (0.61-0.99) 0.90 (0.68-1.20)
RR, risk ratio;CI, confidence interval;ART, assisted reproductive technology;ICSI, intracytoplasmic sperm injection.
*
Adjusted for all covariates in table using log-binomial regression models with generalized estimating equations for correlated outcomes within 
clinics.
†
Pregnancy loss at less than 20 weeks of gestation.
‡
Includes hydrosalpinx, tubal ligation (not reversed), and other tubal disease (not hydrosalpinx).
§
Includes polycystic ovary syndrome.
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